STOCK TITAN

P3 Health Partners Warrant (PIIIW) 10-K Filings

PIIIW NASDAQ

Here are the 10-K annual reports from P3 Health Partners Inc. Warrant (PIIIW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow PIIIW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PIIIW filings page.

Rhea-AI Summary

P3 Health Partners Inc. reports significant financial strain in its 2025 annual filing, with management concluding there is substantial doubt about the company’s ability to continue as a going concern. The company ended December 31, 2025 with $25.0 million in unrestricted cash, $336.7 million of debt (including $45.0 million current), and $287.8 million of unpaid claims, after recording a $323.1 million net loss and building an accumulated deficit of $651.1 million.

P3 operates a physician-led, value-based care platform focused on Medicare Advantage, with capitated contracts where four health plans generated about 75% of 2025 revenue. It manages an "Up‑C" structure and owned roughly 46% of P3 Health Group, LLC as of December 31, 2025.

The filing highlights heavy reliance on raising additional capital in 2026, tight debt covenants that required waivers, and regulatory pressure, including California DMHC finding Medcore HP below required tangible net equity and requiring a corrective action plan. P3 also cites risks around California solvency rules, Nasdaq listing compliance, history of losses, and dependence on a few major payors and physician partners.